| 1 |
26667175 | Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone. | 2016 Mar |
1 |
| 2 |
25149070 | Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. | 2014 Nov |
1 |
| 3 |
24068631 | Xanthophylls, phytosterols and pre-β1-HDL are differentially affected by fenofibrate and niacin HDL-raising in a cross-over study. | 2013 Dec |
1 |
| 4 |
24079282 | Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients. | 2013 Sep-Oct |
1 |
| 5 |
22153696 | Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia. | 2012 Feb |
1 |
| 6 |
23119086 | Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. | 2012 |
1 |
| 7 |
21081177 | Differential regulation of human apolipoprotein AI and high-density lipoprotein by fenofibrate in hapoAI and hapoAI-CIII-AIV transgenic mice. | 2011 Feb |
1 |
| 8 |
21126601 | Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo. | 2011 Feb |
1 |
| 9 |
21696738 | Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy. | 2011 Nov |
1 |
| 10 |
21973199 | Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy. | 2011 Nov |
1 |
| 11 |
24331137 | Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndrome. | 2011 Oct-Dec |
1 |
| 12 |
20197717 | [HDL cholesterol reduction during rosiglitazone and fenofibrate treatment in a type 2 diabetes mellitus patient with dyslipidemia]. | 2010 Feb |
2 |
| 13 |
19057464 | Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study. | 2009 Feb |
2 |
| 14 |
19325138 | Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. | 2009 Jun |
1 |
| 15 |
19555253 | Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients. | 2009 Aug |
2 |
| 16 |
15618549 | Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation. | 2005 Mar |
2 |
| 17 |
15790930 | Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner. | 2005 Jun |
1 |
| 18 |
15920062 | Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia. | 2005 Jun |
1 |
| 19 |
15019537 | Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults. | 2004 Feb |
2 |
| 20 |
24944394 | Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and/or hyperuricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study. | 2003 Jul |
2 |
| 21 |
12017210 | The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide. | 2002 |
1 |
| 22 |
10318668 | Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response. | 1999 May 11 |
2 |
| 23 |
9733211 | Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? | 1998 Sep |
1 |
| 24 |
9298501 | Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. | 1997 Aug |
1 |
| 25 |
8647932 | Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. | 1996 Jun 1 |
4 |
| 26 |
7983038 | Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. | 1994 Dec 9 |
3 |
| 27 |
1311585 | Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate. | 1992 Feb 4 |
4 |
| 28 |
1789814 | Lipoprotein particle analysis comparing simvastatin and fenofibrate. | 1991 Dec |
1 |
| 29 |
2073672 | Safety, tolerability, and efficacy of simvastatin and fenofibrate--a multicenter study. Simvastatin-Fenofibrate Study Group. | 1990 |
1 |
| 30 |
2653621 | Review of the effects of fenofibrate on lipoproteins, apoproteins, and bile saturation: US studies. | 1989 |
1 |
| 31 |
2918846 | Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia. | 1989 Mar |
1 |
| 32 |
3709644 | Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia. | 1986 |
1 |
| 33 |
3924068 | Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia. | 1985 May |
1 |
| 34 |
6870993 | Variations in lipids and proteins of lipoproteins by fenofibrate in some hyperlipoproteinaemic states. | 1983 Apr |
1 |
| 35 |
6811447 | Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia. | 1982 Aug |
2 |